Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lawrence Nathan Shulman, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Pomponio MK, Keele LJ, Fox KR, Clark AS, Matro JM, Shulman LN, Tchou JC. Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer? Breast Cancer Res Treat. 2019 May 22. PMID: 31119565.
    Citations:    
  2. Vapiwala N, Thomas CR, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN. Enhancing Career Paths for Tomorrow's Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2019 May 22. PMID: 31128144.
    Citations:    
  3. Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research and Policy. J Natl Cancer Inst. 2019 May 16. PMID: 31095326.
    Citations:    
  4. Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). Oncologist. 2019 Apr 11. PMID: 30975921.
    Citations:    
  5. Martei YM, Grover S, Bilker WB, Monare B, Setlhako DI, Ralefala TB, Manshimba P, Gross R, Shulman LN, DeMichele A. Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting. J Glob Oncol. 2019 Apr; 5:1-11. PMID: 30969808.
    Citations:    
  6. Shulman LN, Browner AE, Palis BE, Mallin K, Kakade S, Carp N, McCabe R, Winchester D, Wong SL, McKellar DP. Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections. Ann Surg Oncol. 2019 Jun; 26(6):1613-1621. PMID: 30927195.
    Citations:    
  7. Lopez D, Pratt-Chapman ML, Rohan EA, Sheldon LK, Basen-Engquist K, Kline R, Shulman LN, Flores EJ. Establishing effective patient navigation programs in oncology. Support Care Cancer. 2019 Jun; 27(6):1985-1996. PMID: 30887125.
    Citations:    
  8. Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L, Yabroff R, Shulman L, Facktor M, Winchester DP, Nelson H. Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014. Ann Surg Oncol. 2019 Jun; 26(6):1604-1612. PMID: 30737668.
    Citations:    
  9. Velazquez Berumen A, Jimenez Moyao G, Rodriguez NM, Ilbawi AM, Migliore A, Shulman LN. Defining priority medical devices for cancer management: a WHO initiative. Lancet Oncol. 2018 12; 19(12):e709-e719. PMID: 30507437.
    Citations:    Fields:    
  10. Park PH, Davey S, Fehr AE, Butonzi J, Shyirambere C, Hategekimana V, Bigirimana JB, Borg R, Uwizeye R, Tapela N, Shulman LN, Randall T, Mpanumusingo E, Mpunga T. Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda. J Glob Oncol. 2018 12; 4:1-11. PMID: 30582433.
    Citations:    Fields:    
  11. Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi A. Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101. Oncologist. 2019 May; 24(5):617-623. PMID: 30409792.
    Citations:    Fields:    
  12. Neal C, Rusangwa C, Borg R, Mugunga JC, Kennell-Heiling S, Shyirambere C, Pritchett N, Muhayimana C, Ntakirutimana E, Tapela N, Park PH, Shulman LN, Mpunga T. Cost of Treating Pediatric Cancer at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2018 11; 4:1-7. PMID: 30433841.
    Citations:    Fields:    
  13. Martin AN, Silverstein A, Ssebuufu R, Lule J, Mugenzi P, Fehr A, Mpunga T, Shulman LN, Park PH, Costas-Chavarri A. Impact of delayed care on surgical management of patients with gastric cancer in a low-resource setting. J Surg Oncol. 2018 Dec; 118(8):1237-1242. PMID: 30380140.
    Citations:    Fields:    Translation:HumansCells
  14. Hanappe M, Nicholson LT, Elmore SNC, Fehr AE, Bigirimana JB, Borg RC, Butonzi J, Shyirambere C, Mpanumusingo E, Benewe MO, Kanyike DM, Triedman S, Shulman LN, Rusangwa C, Park PH. International Radiotherapy Referrals From Rural Rwanda: Implementation Processes and Early Clinical Outcomes. J Glob Oncol. 2018 Oct; 4:1-12. PMID: 30321096.
    Citations:    Fields:    
  15. Martei YM, Chiyapo S, Grover S, Hanna C, Dryden-Peterson S, Pusoentsi M, Shulman LN, Tapela N. Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries. J Glob Oncol. 2018 Sep; 4:1-8. PMID: 30241244.
    Citations:    Fields:    
  16. Pace LE, Dusengimana JV, Keating NL, Hategekimana V, Rugema V, Bigirimana JB, Costas-Chavarri A, Umwizera A, Park PH, Shulman LN, Mpunga T. Impact of Breast Cancer Early Detection Training on Rwandan Health Workers' Knowledge and Skills. J Glob Oncol. 2018 Sep; 4:1-10. PMID: 30241228.
    Citations:    Fields:    
  17. Martei YM, Chiyapo S, Grover S, Ramogola-Masire D, Dryden-Peterson S, Shulman LN, Tapela N. Availability of WHO Essential Medicines for Cancer Treatment in Botswana. J Glob Oncol. 2018 Sep; 4:1-8. PMID: 30241225.
    Citations:    Fields:    
  18. Garcia-Gonzalez P, Lopes G, Schwartz E, Shulman LN. The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines. J Glob Oncol. 2018 Jul; 4:1-3. PMID: 30084718.
    Citations:    Fields:    
  19. Dusengimana JMV, Hategekimana V, Borg R, Hedt-Gauthier B, Gupta N, Troyan S, Shulman LN, Nzayisenga I, Fadelu T, Mpunga T, Pace LE. Pregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence. BMC Cancer. 2018 Jun 05; 18(1):634. PMID: 29866062.
    Citations:    Fields:    
  20. Tapela NM, Peluso MJ, Kohler RE, Setlhako II, Botebele K, Gabegwe K, Nkele I, Narasimhamurthy M, Mmalane M, Grover S, Barak T, Shulman LN, Lockman S, Dryden-Peterson S. A Step Toward Timely Referral and Early Diagnosis of Cancer: Implementation and Impact on Knowledge of a Primary Care-Based Training Program in Botswana. Front Oncol. 2018; 8:187. PMID: 29896450.
    Citations:    
  21. De La Cruz LM, Shulman LN. 'Under' Surveillance: Impact of Race and Socioeconomic Status on Post-Treatment Breast Cancer Imaging. Ann Surg Oncol. 2018 06; 25(6):1456-1457. PMID: 29516361.
    Citations:    Fields:    
  22. Fadelu T, Shulman LN. Health policy: Towards greater equity in the global oncology workforce. Nat Rev Clin Oncol. 2018 05; 15(5):270-272. PMID: 29485133.
    Citations:    Fields:    
  23. Vapiwala N, Shulman LN, Thomas CR. Care Provider or Service Provider: What Should the Role of Radiation Oncologists Be in the Future? J Oncol Pract. 2018 02; 14(2):81-83. PMID: 29436302.
    Citations:    Fields:    
  24. Martei YM, Pace LE, Brock JE, Shulman LN. Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med. 2018 03; 38(1):161-173. PMID: 29412880.
    Citations:    Fields:    
  25. Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DP. Using the National Cancer Database for Outcomes Research: A Review. JAMA Oncol. 2017 12 01; 3(12):1722-1728. PMID: 28241198.
    Citations: 20     Fields:    
  26. Muvugabigwi G, Nshimiyimana I, Greenberg L, Hakizimana E, Ruhangaza D, Benewe O, Bhai K, Pepoon JR, Fehr AE, Park PH, Butonzi J, Shyirambere C, Manirakiza A, Rusangwa C, Milner D, Mpunga T, Shulman LN. Decreasing Histology Turnaround Time Through Stepwise Innovation and Capacity Building in Rwanda. J Glob Oncol. 2018 Sep; 4:1-6. PMID: 30241136.
    Citations:    Fields:    
  27. Shulman LN, Palis BE, McCabe R, Mallin K, Loomis A, Winchester D, McKellar D. Survival As a Quality Metric of Cancer Care: Use of the National Cancer Data Base to Assess Hospital Performance. J Oncol Pract. 2018 01; 14(1):e59-e72. PMID: 29091535.
    Citations: 1     Fields:    
  28. Rubagumya F, Xu MJ, May L, Driscoll C, Uwizeye FR, Shyirambere C, Larrabee K, Fehr AE, Gilbert UD, Muhayimana C, Hategekimana V, Elmore S, Mpunga T, Moore M, Shulman LN, Lehmann L. Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2018 Sep; 4:1-11. PMID: 30241148.
    Citations:    Fields:    
  29. Martei YM, Binagwaho A, Shulman LN. Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life. JAMA Oncol. 2017 10 01; 3(10):1301-1302. PMID: 28426846.
    Citations: 1     Fields:    
  30. Hortobagyi GN, Pyle D, Cazap EL, El Saghir NS, Shulman LN, Lyman GH, Schnipper LE, Adebamowo CA, Gandara DR, Vose J, Wong SL, Yu P. American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions. J Glob Oncol. 2018 Sep; 4:1-8. PMID: 30241187.
    Citations:    Fields:    
  31. Sharma R, Shulman LN, James T. The Future of Quality Improvement in Breast Cancer: Patient-Reported Outcomes. Am J Med Qual. 2017 Sep/Oct; 32(5):469-471. PMID: 28766360.
    Citations:    Fields:    Translation:Humans
  32. Rubagumya F, Greenberg L, Manirakiza A, DeBoer R, Park PH, Mpunga T, Shulman LN. Increasing global access to cancer care: models of care with non-oncologists as primary providers. Lancet Oncol. 2017 08; 18(8):1000-1002. PMID: 28759361.
    Citations: 2     Fields:    Translation:Humans
  33. Neal C, Rusangwa C, Borg R, Tapela N, Mugunga JC, Pritchett N, Shyirambere C, Ntakirutimana E, Park PH, Shulman LN, Mpunga T. Cost of Providing Quality Cancer Care at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2018 Sep; 4:1-7. PMID: 30241219.
    Citations: 1     Fields:    
  34. O'Neil DS, Keating NL, Dusengimana JMV, Hategekimana V, Umwizera A, Mpunga T, Shulman LN, Pace LE. Quality of Breast Cancer Treatment at a Rural Cancer Center in Rwanda. J Glob Oncol. 2018 Sep; 4:1-11. PMID: 30241207.
    Citations:    Fields:    
  35. Eniu AE, Martei YM, Trimble EL, Shulman LN. Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field. Am Soc Clin Oncol Educ Book. 2017; 37:409-415. PMID: 28561681.
    Citations: 2     Fields:    Translation:Humans
  36. Jacobs LA, Shulman LN. Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol. 2017 01; 18(1):e19-e29. PMID: 28049574.
    Citations: 8     Fields:    Translation:Humans
  37. Liu JB, Huffman KM, Palis BE, Shulman LN, Winchester DP, Ko CY, Hall BL. Reliability of the American College of Surgeons Commission on Cancer's Quality of Care Measures for Hospital and Surgeon Profiling. J Am Coll Surg. 2017 Feb; 224(2):180-190.e8. PMID: 27979711.
    Citations: 1     Fields:    Translation:Humans
  38. Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373. PMID: 27866278.
    Citations:    Fields:    Translation:Humans
  39. Bauml JM, Troxel A, Epperson CN, Cohen RB, Schmitz K, Stricker C, Shulman LN, Bradbury A, Mao JJ, Langer CJ. Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung Cancer. 2016 10; 100:110-113. PMID: 27597289.
    Citations: 2     Fields:    Translation:Humans
  40. Ruddy KJ, Guo H, Baker EL, Goldstein MJ, Mullaney EE, Shulman LN, Partridge AH. Randomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer. 2016 Nov 15; 122(22):3546-3554. PMID: 27459331.
    Citations:    Fields:    
  41. Robertson J, Barr R, Shulman LN, Forte GB, Magrini N. Essential medicines for cancer: WHO recommendations and national priorities. Bull World Health Organ. 2016 Oct 01; 94(10):735-742. PMID: 27843163.
    Citations: 4     Fields:    
  42. Miller ME, Kyrillos A, Yao K, Kantor O, Tseng J, Winchester DJ, Shulman LN. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base. Ann Surg Oncol. 2016 10; 23(10):3337-46. PMID: 27334212.
    Citations: 1     Fields:    Translation:Humans
  43. Shulman LN, Wagner CM, Torode J. Reply to D.W. Felsher et al. J Clin Oncol. 2016 06 20; 34(18):2195. PMID: 27161967.
    Citations:    Fields:    
  44. Pace LE, Shulman LN. Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality. Oncologist. 2016 06; 21(6):739-44. PMID: 27091419.
    Citations: 6     Fields:    Translation:Humans
  45. Pace LE, Dusengimana JM, Hategekimana V, Habineza H, Bigirimana JB, Tapela N, Mutumbira C, Mpanumusingo E, Brock JE, Meserve E, Uwumugambi A, Dillon D, Keating NL, Shulman LN, Mpunga T. Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral Center. Oncologist. 2016 05; 21(5):571-5. PMID: 27009935.
    Citations: 5     Fields:    Translation:Humans
  46. Tapela NM, Mpunga T, Hedt-Gauthier B, Moore M, Mpanumusingo E, Xu MJ, Nzayisenga I, Hategekimana V, Umuhizi DG, Pace LE, Bigirimana JB, Wang J, Driscoll C, Uwizeye FR, Drobac PC, Ngoga G, Shyirambere C, Muhayimana C, Lehmann L, Shulman LN. Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda. BMC Cancer. 2016 Mar 18; 16:237. PMID: 26992690.
    Citations: 7     Fields:    Translation:Humans
  47. Shulman LN, Jacobson JO, Norden AD. Molecular testing for colorectal and lung cancer at an academic cancer center satellite site: Opportunities for improvement. J Clin Oncol. 2016 Mar; 34(7_suppl):229. PMID: 28152690.
    Citations:    
  48. Tapela N, Nzayisenga I, Sethi R, Bigirimana JB, Habineza H, Hategekimana V, Mantini N, Mpunga T, Shulman LN, Lehmann L. Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes. J Glob Oncol. 2016 Jun; 2(3):129-137. PMID: 28717692.
    Citations: 1     Fields:    
  49. Evans TL, Gabriel PE, Shulman LN. Cancer Staging in Electronic Health Records: Strategies to Improve Documentation of These Critical Data. J Oncol Pract. 2016 Feb; 12(2):137-9. PMID: 26869653.
    Citations:    Fields:    Translation:Humans
  50. Shyirambere C, Xu MJ, Elmore SN, Fadelu T, May L, Tapela N, Umuhizi DG, Uwizeye FR, Driscoll C, Muhayimana C, Hategekimana V, Rubagumya F, Nzayisenga I, Shulman LN, Mpunga T, Lehmann LE. Treating Nephroblastoma in Rwanda: Using International Society of Pediatric Oncology Guidelines in a Novel Oncologic Care Model. J Glob Oncol. 2016 Jun; 2(3):105-113. PMID: 28717689.
    Citations: 3     Fields:    
  51. Mpunga T, Hedt-Gauthier BL, Tapela N, Nshimiyimana I, Muvugabigwi G, Pritchett N, Greenberg L, Benewe O, Shulman DS, Pepoon JR, Shulman LN, Milner DA. Implementation and Validation of Telepathology Triage at Cancer Referral Center in Rural Rwanda. J Glob Oncol. 2016 Apr; 2(2):76-82. PMID: 28717686.
    Citations: 4     Fields:    
  52. Stulac S, Mark Munyaneza RB, Chai J, Bigirimana JB, Nyishime M, Tapela N, Chaffee S, Lehmann L, Shulman LN. Initiating Childhood Cancer Treatment in Rural Rwanda: A Partnership-Based Approach. Pediatr Blood Cancer. 2016 May; 63(5):813-7. PMID: 26785111.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  53. Ruff P, Al-Sukhun S, Blanchard C, Shulman LN. Access to Cancer Therapeutics in Low- and Middle-Income Countries. Am Soc Clin Oncol Educ Book. 2016; 35:58-65. PMID: 27249686.
    Citations:    Fields:    Translation:Humans
  54. Vargas SE, Fava JL, Severy L, Rosen RK, Salomon L, Shulman L, Guthrie KM. Psychometric Properties and Validity of a Multi-dimensional Risk Perception Scale Developed in the Context of a Microbicide Acceptability Study. Arch Sex Behav. 2016 Feb; 45(2):415-28. PMID: 26621151.
    Citations: 1     Fields:    Translation:Humans
  55. Shulman LN, Mok TS. Special Issue on Global Cancer Medicine. J Clin Oncol. 2016 01 01; 34(1):1-2. PMID: 26578609.
    Citations: 5     Fields:    Translation:Humans
  56. Tapela NM, Mpunga T, Karema N, Nzayisenga I, Fadelu T, Uwizeye FR, Hirschhorn LR, Muhimpundu MA, Balinda JP, Amoroso C, Wagner CM, Binagwaho A, Shulman LN. Implementation Science for Global Oncology: The Imperative to Evaluate the Safety and Efficacy of Cancer Care Delivery. J Clin Oncol. 2016 Jan 01; 34(1):43-52. PMID: 26578617.
    Citations: 4     Fields:    Translation:Humans
  57. Shulman LN, Wagner CM, Barr R, Lopes G, Longo G, Robertson J, Forte G, Torode J, Magrini N. Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes. J Clin Oncol. 2016 Jan 01; 34(1):69-75. PMID: 26578613.
    Citations: 12     Fields:    Translation:Humans
  58. Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):493-6. PMID: 26460990.
    Citations:    Fields:    Translation:Humans
  59. Stulac S, Binagwaho A, Tapela NM, Wagner CM, Muhimpundu MA, Ngabo F, Nsanzimana S, Kayonde L, Bigirimana JB, Lessard AJ, Lehmann L, Shulman LN, Nutt CT, Drobac P, Mpunga T, Farmer PE. Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience. Lancet Oncol. 2015 Aug; 16(8):e405-13. PMID: 26248848.
    Citations: 10     Fields:    Translation:Humans
  60. Mallin K, Loomis AM, Palis B, Shulman LN, Winchester DP. Regarding 'Opportunity lost: Adjuvant chemotherapy in patients with Stage III colon cancer remains underused'. Surgery. 2015 Dec; 158(6):1745-6. PMID: 26209571.
    Citations:    Fields:    Translation:Humans
  61. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem". Front Oncol. 2015; 5:133. PMID: 26114095.
    Citations:    
  62. Pace LE, Mpunga T, Hategekimana V, Dusengimana JM, Habineza H, Bigirimana JB, Mutumbira C, Mpanumusingo E, Ngiruwera JP, Tapela N, Amoroso C, Shulman LN, Keating NL. Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. Oncologist. 2015 Jul; 20(7):780-8. PMID: 26032138.
    Citations: 17     Fields:    Translation:Humans
  63. Riesel JN, Mandigo M, Gillies R, Damuse R, Farmer PE, Cusack JC, Krakauer EL, Shulman LN. Surgical palliative care in resource-limited settings. Lancet. 2015 Aug 08; 386(9993):527. PMID: 25924837.
    Citations: 1     Fields:    Translation:Humans
  64. Shulman LN, McCabe R, Gay G, Palis B, McKellar D. Building Data Infrastructure to Evaluate and Improve Quality: The National Cancer Data Base and the Commission on Cancer's Quality Improvement Programs. J Oncol Pract. 2015 May; 11(3):209-12. PMID: 25901051.
    Citations:    Fields:    Translation:Humans
  65. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training global oncologists: addressing the global cancer control problem. Front Oncol. 2015; 5:80. PMID: 25905040.
    Citations: 1     
  66. Warner JL, Maddux SE, Hughes KS, Krauss JC, Yu PP, Shulman LN, Mayer DK, Hogarth M, Shafarman M, Stover Fiscalini A, Esserman L, Alschuler L, Koromia GA, Gonzaga Z, Ambinder EP. Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization. J Am Med Inform Assoc. 2015 May; 22(3):577-86. PMID: 25604811.
    Citations: 4     Fields:    Translation:Humans
  67. Son BH, Dominici LS, Aydogan F, Shulman LN, Ahn SH, Cho JY, Coopey SB, Kim SB, Min HE, Valero M, Wang J, Caragacianu D, Gong GY, Hevelone ND, Baek S, Golshan M. Young women with breast cancer in the United States and South Korea: comparison of demographics, pathology and management. Asian Pac J Cancer Prev. 2015; 16(6):2531-5. PMID: 25824792.
    Citations: 2     Fields:    Translation:Humans
  68. Shulman LN. Cancer care quality: current state and future directions. Am Soc Clin Oncol Educ Book. 2015; e337-41. PMID: 25993194.
    Citations:    Fields:    Translation:Humans
  69. Shulman LN, Berry DA, Cirrincione CT, Hudis CA, Winer EP. Reply to V. Amoroso et al. J Clin Oncol. 2015 Jan 20; 33(3):291. PMID: 25512457.
    Citations:    Fields:    Translation:Humans
  70. Shulman LN, Ferris L, Takanishi DM, McKellar D. Treatment Summaries and Survivorship Care Plans: The Approach by the Commission on Cancer to Increase Use. J Oncol Pract. 2015 01; 11(1):40-1. PMID: 25424651.
    Citations: 2     Fields:    Translation:Humans
  71. Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. Front Oncol. 2014; 4:333. PMID: 25478326.
    Citations: 5     
  72. Shulman LN, Mpunga T, Tapela N, Wagner CM, Fadelu T, Binagwaho A. Bringing cancer care to the poor: experiences from Rwanda. Nat Rev Cancer. 2014 12; 14(12):815-21. PMID: 25355378.
    Citations: 21     Fields:    Translation:Humans
  73. Mayer DK, Nekhlyudov L, Snyder CF, Merrill JK, Wollins DS, Shulman LN. American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning. J Oncol Pract. 2014 Nov; 10(6):345-51. PMID: 25316025.
    Citations: 17     Fields:    Translation:Humans
  74. Mpunga T, Tapela N, Hedt-Gauthier BL, Milner D, Nshimiyimana I, Muvugabigwi G, Moore M, Shulman DS, Pepoon JR, Shulman LN. Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settings. Am J Clin Pathol. 2014 Oct; 142(4):541-5. PMID: 25239422.
    Citations: 15     Fields:    Translation:Humans
  75. Glaser MS, Shah N, Webber MP, Zeig-Owens R, Jaber N, Appel DW, Hall CB, Weakley J, Cohen HW, Shulman L, Kelly K, Prezant D. Obstructive sleep apnea and World Trade Center exposure. J Occup Environ Med. 2014 Oct; 56 Suppl 10:S30-4. PMID: 25285973.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  76. Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol. 2014 Sep 20; 32(27):2959-66. PMID: 25071121.
    Citations: 194     Fields:    Translation:HumansCells
  77. Steingisser L, Acker B, Berman S, Brenner MJ, Bornstein BA, Busse P, FitzGerald TJ, Jacobson JO, Jekowsky E, Kachnic LA, Mamon H, McKee A, Shulman LN, Stevenson MA, Wazer D, Fallon JA. Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology. J Oncol Pract. 2014 Sep; 10(5):e321-7. PMID: 25232190.
    Citations: 3     Fields:    Translation:Humans
  78. Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA. Occult primary, version 3.2014. J Natl Compr Canc Netw. 2014 Jul; 12(7):969-74. PMID: 24994917.
    Citations: 5     Fields:    Translation:Humans
  79. Mubiligi JM, Hedt-Gauthier B, Mpunga T, Tapela N, Okao P, Harries AD, Edginton ME, Driscoll C, Mugabo L, Riviello R, Shulman LN. Caring for patients with surgically resectable cancers: experience from a specialised centre in rural Rwanda. Public Health Action. 2014 Jun 21; 4(2):128-32. PMID: 26399213.
    Citations: 4     
  80. Shulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R, Martino S, Shapiro CL, Schneider CJ, Kimmick G, Burstein HJ, Norton L, Muss H, Hudis CA, Winer EP. Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance). J Clin Oncol. 2014 Aug 01; 32(22):2311-7. PMID: 24934787.
    Citations: 14     Fields:    Translation:Humans
  81. Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, Ngabo F, Wagner CM, Nutt CT, Nyatanyi T, Gatera M, Kayiteshonga Y, Mugeni C, Mugwaneza P, Shema J, Uwaliraye P, Gaju E, Muhimpundu MA, Dushime T, Senyana F, Mazarati JB, Gaju CM, Tuyisenge L, Mutabazi V, Kyamanywa P, Rusanganwa V, Nyemazi JP, Umutoni A, Kankindi I, Ntizimira C, Ruton H, Mugume N, Nkunda D, Ndenga E, Mubiligi JM, Kakoma JB, Karita E, Sekabaraga C, Rusingiza E, Rich ML, Mukherjee JS, Rhatigan J, Cancedda C, Bertrand-Farmer D, Bukhman G, Stulac SN, Tapela NM, van der Hoof Holstein C, Shulman LN, Habinshuti A, Bonds MH, Wilkes MS, Lu C, Smith-Fawzi MC, Swain JD, Murphy MP, Ricks A, Kerry VB, Bush BP, Siegler RW, Stern CS, Sliney A, Nuthulaganti T, Karangwa I, Pegurri E, Dahl O, Drobac PC. Rwanda 20 years on: investing in life. Lancet. 2014 Jul 26; 384(9940):371-5. PMID: 24703831.
    Citations: 38     Fields:    Translation:Humans
  82. Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, Ritchie MD, Plenge RM, Witte JS, Kroetz DL. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J. 2014 Aug; 14(4):336-42. PMID: 24513692.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  83. Shulman LN. The effect of accountable care organizations on oncology practice. Am Soc Clin Oncol Educ Book. 2014; e468-71. PMID: 24857141.
    Citations: 1     Fields:    Translation:Humans
  84. Dalby CK, Anastas S, Brady L, Hassett MJ, Shulman LN, Jacobson JO. Implementation of chemotherapy treatment plans (CTP) in a large comprehensive cancer center (CCC): The key roles of infrastructure and data sharing. J Clin Oncol. 2013 Nov; 31(31_suppl):20. PMID: 28136255.
    Citations:    
  85. Mtonga P, Masamba L, Milner D, Shulman LN, Nyirenda R, Mwafulirwa K. Biopsy case mix and diagnostic yield at a Malawian central hospital. Malawi Med J. 2013 Sep; 25(3):62-4. PMID: 24358421.
    Citations: 4     Fields:    Translation:Humans
  86. Sharma K, Costas A, Damuse R, Hamiltong-Pierre J, Pyda J, Ong CT, Shulman LN, Meara JG. The Haiti Breast Cancer Initiative: Initial Findings and Analysis of Barriers-to-Care Delaying Patient Presentation. J Oncol. 2013; 2013:206367. PMID: 23840209.
    Citations: 5     
  87. Shulman LN, Mamon H, Jacobson JO, Steingisser L, Dodek A, Fallon JA. Partnership between a cancer center and payer: opportunities for improved quality of care and cost reduction. J Oncol Pract. 2013 May; 9(3):133-4. PMID: 23942490.
    Citations:    Fields:    Translation:Humans
  88. Silva TB, Mauad EC, Carvalho AL, Jacobs LA, Shulman LN. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods. Rural Remote Health. 2013 Apr-Jun; 13(2):2321. PMID: 23597169.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  89. LeBlanc TW, Shulman LN, Yu PP, Hirsch BR, Abernethy AP. The ethics of health information technology in oncology: emerging isssues from both local and global perspectives. Am Soc Clin Oncol Educ Book. 2013; 136-42. PMID: 23714480.
    Citations:    Fields:    Translation:Humans
  90. Shulman LN. Efficient and effective models for integrating advanced practice professionals into oncology practice. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714553.
    Citations: 1     Fields:    Translation:Humans
  91. Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ. Tumor boards and the quality of cancer care. J Natl Cancer Inst. 2013 Jan 16; 105(2):113-21. PMID: 23274388.
    Citations: 30     Fields:    Translation:Humans
  92. Buswell LA, Amorati M, Arthur L, Bernard A, Constantine M, Dalby C, Farrar W, Fuller F, Kerivan D, Lacourse K, McNulty BD, Racicot A, Spinks M, Jacobson JO, Ponte PR, Shulman LN. Wait time reduction for patients awaiting chemotherapy infusion using a formal process improvement approach and sequential. J Clin Oncol. 2012 Dec; 30(34_suppl):92. PMID: 28147072.
    Citations:    
  93. Wheeler HE, Gamazon ER, Wing C, Njiaju UO, Njoku C, Baldwin RM, Owzar K, Jiang C, Watson D, Shterev I, Kubo M, Zembutsu H, Winer EP, Hudis CA, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL, Cox NJ, Dolan ME. Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2013 Jan 15; 19(2):491-9. PMID: 23204130.
    Citations: 25     Fields:    Translation:HumansCells
  94. Weingart SN, Cleary A, Scullion B, Morway L, Phantumvanit V, Stuver SO, Shulman LN, Connors JM. Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology. J Oncol Pharm Pract. 2013 Sep; 19(3):237-45. PMID: 23175451.
    Citations: 1     Fields:    Translation:Humans
  95. Miriovsky BJ, Shulman LN, Abernethy AP. Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol. 2012 Dec 01; 30(34):4243-8. PMID: 23071233.
    Citations: 25     Fields:    Translation:Humans
  96. Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M. Improving electronic oral chemotherapy prescription: can we build a safer system? J Oncol Pract. 2012 Nov; 8(6):e168-73. PMID: 23598852.
    Citations: 4     Fields:    Translation:Humans
  97. Sharma K, Costas A, Shulman LN, Meara JG. A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol. 2012; 2012:121873. PMID: 22956949.
    Citations: 26     
  98. Kahn MJ, Ma AD, Shulman LN. Update in hematology and medical oncology: evidence published in 2011. Ann Intern Med. 2012 Aug 21; 157(4):276-83. PMID: 22910938.
    Citations:    Fields:    Translation:Humans
  99. Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res. 2012 Sep 15; 18(18):5099-109. PMID: 22843789.
    Citations: 51     Fields:    Translation:HumansCells
  100. Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis C. Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. J Clin Oncol. 2012 Nov 20; 30(33):4071-6. PMID: 22826271.
    Citations: 26     Fields:    Translation:HumansCTClinical Trials
  101. Knaul FM, Shulman LN, Gralow J, Quick J, Bhadelia A, Frenk J. Improving pathology for better cancer care and control in countries of low and middle income. Lancet. 2012 Jun 02; 379(9831):2052. PMID: 22656884.
    Citations: 2     Fields:    Translation:Humans
  102. Gatzos LC, Barbetti S, Bas-Davis S, Mailman A, Brzezinski P, Ruseau P, Barr Vermilya H, Schott D, Marston E, Sturtevant OJ, Ritz J, Shulman LN. Development and implementation of a computerized system for collection, processing, and administration of cellular therapy products. J Oncol Pract. 2012 Sep; 8(5):262-6. PMID: 23277761.
    Citations:    Fields:    Translation:Humans
  103. Solin LJ, Gray R, Goldstein LJ, Recht A, Baehner FL, Shak S, Badve S, Perez EA, Shulman LN, Martino S, Davidson NE, Sledge GW, Sparano JA. Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Res Treat. 2012 Jul; 134(2):683-92. PMID: 22547108.
    Citations: 12     Fields:    Translation:HumansCells
  104. Peppercorn J, Shapira I, Deshields T, Kroetz D, Friedman P, Spears P, Collyar DE, Shulman LN, Dressler L, Bertagnolli MM. Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience. Cancer. 2012 Oct 15; 118(20):5060-8. PMID: 22415847.
    Citations: 5     Fields:    Translation:Humans
  105. Landrum MB, Keating NL, Lamont EB, Bozeman SR, Krasnow SH, Shulman L, Brown JR, Earle CC, Rabin M, McNeil BJ. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol. 2012 Apr 01; 30(10):1072-9. PMID: 22393093.
    Citations: 20     Fields:    Translation:Humans
  106. Shulman LN. Bringing cancer care to those who don't have it. Narrat Inq Bioeth. 2012; 2(2):E10-2. PMID: 24406837.
    Citations:    Fields:    Translation:Humans
  107. Weingart SN, Li JW, Zhu J, Morway L, Stuver SO, Shulman LN, Hassett MJ. US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards. J Oncol Pract. 2012 Jan; 8(1):7-12. PMID: 22548004.
    Citations: 6     Fields:    
  108. Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen WK. NCCN Clinical Practice Guidelines Occult primary. J Natl Compr Canc Netw. 2011 Dec; 9(12):1358-95. PMID: 22157556.
    Citations: 8     Fields:    Translation:Humans
  109. Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011 Dec; 37(12):568-75. PMID: 22235542.
    Citations: 2     Fields:    Translation:Humans
  110. Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray R. Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer. Clin Cancer Res. 2011 Nov 15; 17(22):7194-203. PMID: 21933890.
    Citations: 5     Fields:    Translation:Humans
  111. Beckjord EB, Rechis R, Nutt S, Shulman L, Hesse BW. What Do People Affected by Cancer Think About Electronic Health Information Exchange? Results From the 2010 LIVESTRONG Electronic Health Information Exchange Survey and the 2008 Health Information National Trends Survey. J Oncol Pract. 2011 Jul; 7(4):237-41. PMID: 22043188.
    Citations: 15     Fields:    
  112. Keating NL, Landrum MB, Lamont EB, Bozeman SR, Krasnow SH, Shulman LN, Brown JR, Earle CC, Oh WK, Rabin M, McNeil BJ. Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med. 2011 Jun 07; 154(11):727-36. PMID: 21646556.
    Citations: 28     Fields:    Translation:Humans
  113. Beckjord EB, Rechis R, Shulman LN, Hesse B. Perspectives on electronic health information exchange among people affected by cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):6123. PMID: 28022502.
    Citations:    
  114. Neuss MN, Flamm C, Shulman LN, Tomkins JE, Ward JC. Report on the ASCO 2010 Provider-Payer Initiative Meeting. J Oncol Pract. 2011 May; 7(3):136-40. PMID: 21886491.
    Citations: 1     Fields:    
  115. Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, Thompson B, Winchester DP, Zelle SG, Badwe RA. Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast. 2011 Apr; 20 Suppl 2:S20-9. PMID: 21376593.
    Citations: 14     Fields:    Translation:Humans
  116. Shulman LN, Willett W, Sievers A, Knaul FM. Breast cancer in developing countries: opportunities for improved survival. J Oncol. 2010; 2010:595167. PMID: 21253541.
    Citations: 32     
  117. Bunnell CA, Shulman LN. Will we be able to care for cancer patients in the future? Oncology (Williston Park). 2010 Dec; 24(14):1343-8. PMID: 21294481.
    Citations: 7     Fields:    Translation:Humans
  118. Bunnell CA, Weingart SN, Swanson S, Mamon HJ, Shulman LN. Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center. J Oncol Pract. 2010 Nov; 6(6):283-8. PMID: 21358956.
    Citations: 6     Fields:    
  119. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, Atun R, Blayney D, Chen L, Feachem R, Gospodarowicz M, Gralow J, Gupta S, Langer A, Lob-Levyt J, Neal C, Mbewu A, Mired D, Piot P, Reddy KS, Sachs JD, Sarhan M, Seffrin JR. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010 Oct 02; 376(9747):1186-93. PMID: 20709386.
    Citations: 143     Fields:    Translation:HumansPHPublic Health
  120. Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S, Miransky J, Partridge A, Shulman LN, Connor M. Medication errors involving oral chemotherapy. Cancer. 2010 May 15; 116(10):2455-64. PMID: 20225328.
    Citations: 14     Fields:    Translation:Humans
  121. Drews RE, Shulman LN. Update in hematology and oncology. Ann Intern Med. 2010 May 18; 152(10):655-62. PMID: 20410447.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  122. Carlson JW, Lyon E, Walton D, Foo WC, Sievers AC, Shulman LN, Farmer P, Nosé V, Milner DA. Partners in pathology: a collaborative model to bring pathology to resource poor settings. Am J Surg Pathol. 2010 Jan; 34(1):118-23. PMID: 19898229.
    Citations: 9     Fields:    Translation:Humans
  123. Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez E, Shulman LN, Martino S, Davidson NE, Sledge GW, Gray R. Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clin Cancer Res. 2009 Dec 15; 15(24):7693-7700. PMID: 19996222.
    Citations: 12     Fields:    
  124. Toruner GA, Kurvathi R, Sugalski R, Shulman L, Twersky S, Pearson PG, Tozzi R, Schwalb MN, Wallerstein R. Copy number variations in three children with sudden infant death. Clin Genet. 2009 Jul; 76(1):63-8. PMID: 19659761.
    Citations: 5     Fields:    Translation:Humans
  125. Buswell LA, Ponte PR, Shulman LN. Provider practice models in ambulatory oncology practice: analysis of productivity, revenue, and provider and patient satisfaction. J Oncol Pract. 2009 Jul; 5(4):188-92. PMID: 20856635.
    Citations: 9     Fields:    
  126. Shulman LN, Jacobs LA, Greenfield S, Jones B, McCabe MS, Syrjala K, Diller L, Shapiro CL, Marcus AC, Campbell M, Santacroce S, Kagawa-Singer M, Ganz PA. Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract. 2009 May; 5(3):119-23. PMID: 20856750.
    Citations: 18     Fields:    
  127. Weingart SN, Saadeh MG, Simchowitz B, Gandhi TK, Nekhlyudov L, Studdert DM, Puopolo AL, Shulman LN. Process of care failures in breast cancer diagnosis. J Gen Intern Med. 2009 Jun; 24(6):702-9. PMID: 19387748.
    Citations: 6     Fields:    Translation:Humans
  128. Burstein HJ, Chen YH, Parker LM, Savoie J, Younger J, Kuter I, Ryan PD, Garber JE, Chen H, Campos SM, Shulman LN, Harris LN, Gelman R, Winer EP. VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clin Cancer Res. 2008 Dec 01; 14(23):7871-7. PMID: 19047116.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  129. Ettinger DS, Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handorf C, Harris EI, Jacobs CD, Javle M, Khushalani NI, Kvols L, Lenzi R, Lewis NL, Rashid A, Saltz L, Shulman LN, Zager JS, Zhen W. Occult primary. J Natl Compr Canc Netw. 2008 Nov; 6(10):1026-60. PMID: 19176200.
    Citations:    Fields:    Translation:Humans
  130. Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JV. Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 2 of 2. J Oncol Pract. 2008 Sep; 4(5):254-257. PMID: 29452528.
    Citations: 1     Fields:    
  131. Goldstein LJ, Gray R, Badve S, Childs BH, Yoshizawa C, Rowley S, Shak S, Baehner FL, Ravdin PM, Davidson NE, Sledge GW, Perez EA, Shulman LN, Martino S, Sparano JA. Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol. 2008 Sep 01; 26(25):4063-71. PMID: 18678838.
    Citations: 85     Fields:    Translation:HumansCTClinical Trials
  132. Goldstein LJ, O'Neill A, Sparano JA, Perez EA, Shulman LN, Martino S, Davidson NE. Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197. J Clin Oncol. 2008 Sep 01; 26(25):4092-9. PMID: 18678836.
    Citations: 31     Fields:    Translation:Humans
  133. Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JV. Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 1 of 2. J Oncol Pract. 2008 Jul; 4(4):203-206. PMID: 29447501.
    Citations: 1     Fields:    
  134. Bansal A, Binkert CA, Robinson MK, Shulman LN, Pellerin L, Davison B. Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting. J Vasc Interv Radiol. 2008 Aug; 19(8):1171-5. PMID: 18656009.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  135. Hwang D, Shakir N, Limann B, Sison C, Kalra S, Shulman L, Souza Ade C, Greenberg H. Association of sleep-disordered breathing with postoperative complications. Chest. 2008 May; 133(5):1128-34. PMID: 18339794.
    Citations: 41     Fields:    Translation:Humans
  136. Shulman LN, Hitt RA, Ferry JA. Case records of the Massachusetts General Hospital. Case 4-2008. A 33-year-old pregnant woman with swelling of the left breast and shortness of breath. N Engl J Med. 2008 Jan 31; 358(5):513-23. PMID: 18234756.
    Citations: 1     Fields:    Translation:Humans
  137. Weingart SN, Cleary A, Seger A, Eng TK, Saadeh M, Gross A, Shulman LN. Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007 Dec; 33(12):750-7. PMID: 18200900.
    Citations: 12     Fields:    Translation:Humans
  138. Tolaney SM, Colson YL, Gill RR, Schulte S, Duggan MM, Shulman LN, Winer EP. Sarcoidosis mimicking metastatic breast cancer. Clin Breast Cancer. 2007 Oct; 7(10):804-10. PMID: 18021484.
    Citations: 9     Fields:    Translation:Humans
  139. Lin NU, Parker LM, Come SE, Burstein HJ, Haldoupis M, Ryabin N, Gelman R, Winer EP, Shulman LN. Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions. Invest New Drugs. 2007 Aug; 25(4):369-75. PMID: 17345004.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  140. Morrow KM, Vargas S, Rosen RK, Christensen AL, Salomon L, Shulman L, Barroso C, Fava JL. The utility of non-proportional quota sampling for recruiting at-risk women for microbicide research. AIDS Behav. 2007 Jul; 11(4):586-95. PMID: 17333312.
    Citations: 6     Fields:    Translation:Humans
  141. Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 2007 Jan 20; 25(3):313-8. PMID: 17235046.
    Citations: 50     Fields:    Translation:HumansCTClinical Trials
  142. Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007 Feb 24; 334(7590):407. PMID: 17223629.
    Citations: 30     Fields:    Translation:Humans
  143. Shulman, LN. Multidisciplinary breast cancer care: perspectives from team members at Dana-Farber Cancer Institute/Multidisciplinary breast cancer care from the point of view of the medical oncologist. Am J Hematol Oncol. 2007; 6:17-18.
  144. Balogh GA, Mailo DA, Corte MM, Roncoroni P, Nardi H, Vincent E, Martinez D, Cafasso ME, Frizza A, Ponce G, Vincent E, Barutta E, Lizarraga P, Lizarraga G, Monti C, Paolillo E, Vincent R, Quatroquio R, Grimi C, Maturi H, Aimale M, Spinsanti C, Montero H, Santiago J, Shulman L, Rivadulla M, Machiavelli M, Salum G, Cuevas MA, Picolini J, Gentili A, Gentili R, Mordoh J. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer. Int J Oncol. 2006 Apr; 28(4):995-1002. PMID: 16525651.
    Citations: 8     Fields:    Translation:Humans
  145. Hassett MJ, Shulman LN. A tale of two taxanes: Docetaxel or paclitaxel for advanced or metastatic breast cancer. Am J Oncol Rev. 2006; 5:162-4.
  146. Sundaram R, Shulman L, Fein AM. Trends in tobacco use. Clin Occup Environ Med. 2006; 5(1):1-7, vii. PMID: 16446250.
    Citations:    Fields:    Translation:Humans
  147. Gandhi TK, Bartel SB, Shulman LN, Verrier D, Burdick E, Cleary A, Rothschild JM, Leape LL, Bates DW. Medication safety in the ambulatory chemotherapy setting. Cancer. 2005 Dec 01; 104(11):2477-83. PMID: 16245353.
    Citations: 30     Fields:    Translation:Humans
  148. Goldstein LJ, O'Neill A, Sparano J, Perez E, Shulman L, Martino S, Davidson N. E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):512. PMID: 27946381.
    Citations:    
  149. Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, Harris JR, Recht A. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20; 23(9):1934-40. PMID: 15774786.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  150. Ettinger DS, Arnoletti JP, Gockerman JP, Handorf C, Havlin KA, Jacobs CD, Javle M, Kvols L, Lenzi R, Rashid A, Rhoades CA, Ridge JA, Saltz L, Shulman LN, Sondak VK, Thompson JA, Twardowski P, Zhen W. Occult primary cancer clinical practice guidelines. J Natl Compr Canc Netw. 2005 Mar; 3(2):214-33. PMID: 19817031.
    Citations: 1     Fields:    Translation:Humans
  151. Pizziferri L, Kittler AF, Volk LA, Shulman LN, Kessler J, Carlson G, Michaelidis T, Bates DW. Impact of an Electronic Health Record on oncologists' clinic time. AMIA Annu Symp Proc. 2005; 1083. PMID: 16779370.
    Citations: 2     Fields:    Translation:Humans
  152. Shulman L, Ost D. Managing infection in the critical care unit: how can infection control make the ICU safe? Crit Care Clin. 2005 Jan; 21(1):111-28, ix. PMID: 15579356.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  153. Sundaram R, Shulman L, Fein AM. Trends in tobacco use. Med Clin North Am. 2004 Nov; 88(6):1391-7, ix. PMID: 15464103.
    Citations:    Fields:    Translation:Humans
  154. McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors. Am J Clin Oncol. 2004 Oct; 27(5):485-8. PMID: 15596916.
    Citations: 23     Fields:    Translation:Humans
  155. Shedlin MG, Shulman L. Qualitative needs assessment of HIV services among Dominican, Mexican and Central American immigrant populations living in the New York City area. AIDS Care. 2004 May; 16(4):434-45. PMID: 15203412.
    Citations: 15     Fields:    Translation:Humans
  156. Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, Harris JR, Recht A. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer. 2004 Apr 01; 100(7):1358-64. PMID: 15042668.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  157. Lukanich JM, Sugarbaker DJ, Shulman LN. Malignant effusions. . Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast. 2004; 1261-72.
  158. Mentzer SJ, Sugarbaker DJ, Shulman LN. Management of Discrete Pulmonary Nodules. Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast. 2004; 1273-8.
  159. Nadler E, Shulman LN. High-dose, stem cell supported chemotherapy vs conventional chemotherapy as treatment for patients with locally advanced breast cancer: Do randomized trials settle the debate?. Am J Oncol Rev. 2004; 3:36-38.
  160. Canellos GP, Gollub J, Neuberg D, Mauch P, Shulman LN. Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. Ann Oncol. 2003 Feb; 14(2):268-72. PMID: 12562654.
    Citations: 5     Fields:    Translation:Humans
  161. Ponte PR, Conlin G, Conway JB, Grant S, Medeiros C, Nies J, Shulman L, Branowicki P, Conley K. Making patient-centered care come alive: achieving full integration of the patient's perspective. J Nurs Adm. 2003 Feb; 33(2):82-90. PMID: 12584460.
    Citations: 6     Fields:    Translation:Humans
  162. Bellon JR, Shulman LN. Breast-conserving surgery vs mastectomy: How much data do we need to gain widespread acceptance and utilization? (commentary). Am J Oncol Rev. 2003; 2:42-4.
  163. Hassett MJ, Shulman LN. Dose-dense chemotherapy as adjuvant therapy for node-positive breast cancer: Does this work and why?. Am J Oncol Rev. 2003; 2:378-81.
  164. Shulman LN. Lessons learned from the MD Anderson adjuvant trials exploring sequential chemotherapy. Am J Oncol Rev. 2003; 2:454-5.
  165. Eder JP, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol. 2002 Sep 15; 20(18):3772-84. PMID: 12228197.
    Citations: 44     Fields:    Translation:HumansCTClinical Trials
  166. Vasey PA, Shulman LN, Campos S, Davis J, Gore M, Johnston S, Kirn DH, O'Neill V, Siddiqui N, Seiden MV, Kaye SB. Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J Clin Oncol. 2002 Mar 15; 20(6):1562-9. PMID: 11896105.
    Citations: 47     Fields:    Translation:HumansCellsCTClinical Trials
  167. Shulman LN, Cady B, Kopans DB, Oratz R. Mammography screening for breast cancer: The data behind the debate. Medical Crossfire. 2002; 4:34-45.
  168. Shulman LN. Neoadjuvant chemotherapy followed by mastectomy: Who need radiation? (commentary). Am J Oncol Rev. 2002; 1:20-1.
  169. Shulman LN, Cutler CS. Non-gynecologic cancer in pregnancy. Carlson K, Eisenstat SA, eds. Primary care of women. 2002; 540-5.
  170. Shulman LN. Chemotherapy in the treatment of patients with metastatic breast cancer: High-dose, low-dose - What have we accomplished? (commentary). Am J Oncol Rev. 2002; 1:169-70.
  171. Shulman LN. What is the ideal duration of adjuvant therapy for primary breast cancer: are four cycles of cyclophosphamide and doxorubicin enough? Curr Oncol Rep. 2001 Nov; 3(6):523-8. PMID: 11595121.
    Citations:    Fields:    Translation:Humans
  172. Bunnell CA, Supko JG, Eder JP, Clark JW, Lynch TJ, Kufe DW, Shulman LN. Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies. Cancer Chemother Pharmacol. 2001 Nov; 48(5):347-55. PMID: 11761451.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  173. Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2001 May 15; 19(10):2722-30. PMID: 11352965.
    Citations: 57     Fields:    Translation:HumansCTClinical Trials
  174. Shinnar S, Rapin I, Arnold S, Tuchman RF, Shulman L, Ballaban-Gil K, Maw M, Deuel RK, Volkmar FR. Language regression in childhood. Pediatr Neurol. 2001 Mar; 24(3):183-9. PMID: 11301218.
    Citations: 27     Fields:    Translation:Humans
  175. Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M, Pahwa R, McGuire D, Lew MF, Schuman S, Marek K, Broshjeit S, Factor S, Brown D, Feigin A, Mazurkiewicz J, Ford B, Jennings D, Dilllon S, Comella C, Blasucci L, Janko K, Shulman L, Wiener W, Bateman-Rodriguez D, Carrion A, Suchowersky O, Lafontaine AL, Pantella C, Siemers E, Belden J, Davies R, Lannon M, Grimes D, Gray P, Martin W, Kennedy L, Adler C, Newman S, Hammerstad J, Stone C, Lewitt P, Bardram K, Mistura K, Miyasaki J, Johnston L, Cha JH, Tennis M, Panniset M, Hall J, Tetrud J, Friedlander J, Hauser R, Gauger L, Rodnitzky R, Deleo A, Dobson J, Seeberger L, Dingmann C, Tarsy D, Ryan P, Elmer L, Ruzicka D, Stacy M, Brewer M, Locke B, Baker D, Casaceli C, Day D, Florack M, Hodgeman K, Laroia N, Nobel R, Orme C, Rexo L, Rothenburgh K, Sulimowicz K, Watts A, Wratni E, Tariot P, Cox C, Leventhal C, Alderfer V, Craun AM, Frey J, McCree L, McDermott J, Cooper J, Holdich T, Read B. A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology. 2001 Feb 27; 56(4):455-62. PMID: 11222787.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  176. Jacobson JO, Grossbard M, Shulman LN, Neuberg D. CHOP chemotherapy with preemptive granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma: a dose-intensity analysis. Clin Lymphoma. 2000 Dec; 1(3):211-7; discussion 218. PMID: 11707832.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  177. Sternberg DW, Aird W, Neuberg D, Thompson L, MacNeill K, Amrein P, Shulman LN. Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen. Cancer. 2000 May 01; 88(9):2037-41. PMID: 10813714.
    Citations: 1     Fields:    Translation:Humans
  178. Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EP. Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol. 2000 Mar; 18(6):1212-9. PMID: 10715290.
    Citations: 38     Fields:    Translation:HumansCTClinical Trials
  179. Ramaswamy S, Osteen RT, Shulman LN. Metastatic cancer from an unknown primary site. Lenhard Jr RE, Osteen RT, Gansler T, eds. The American Cancer Society's Clinical Oncology. 2000; 711-9.
  180. Shulman LN, Sugarbaker DJ. Malignant effusions. Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast. 2000; 893-900.
  181. Miller KD, Picus J, Blanke C, John W, Clark J, Shulman LN, Thornton D, Rowinsky E, Loehrer PJ. Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer. Ann Oncol. 2000 Jan; 11(1):101-3. PMID: 10690396.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  182. Shulman L, Mahallati H, Gray R. Soft-tissue case 30. Presentation. Pelvic trauma: detection of active bleeding by computed tomography. Can J Surg. 1999 Dec; 42(6):413, 420. PMID: 10593239.
    Citations:    Fields:    Translation:Humans
  183. Dubey A, Recht A, Come SE, Gelman RS, Silver B, Harris JR, Shulman LN. Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. Int J Radiat Oncol Biol Phys. 1999 Nov 01; 45(4):877-84. PMID: 10571193.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  184. Gray RR, Sadler DJ, Shulman L, Saliken JC, So CB. Should anticoagulant therapy be stopped or reversed before venous intervention? Can Assoc Radiol J. 1999 Oct; 50(5):306-9. PMID: 10555503.
    Citations: 1     Fields:    Translation:Humans
  185. Hardenbergh PH, Recht A, Gollamudi S, Come SE, Hayes DF, Shulman LN, O'Neill A, Gelman RS, Silver B, Harris JR. Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):69-72. PMID: 10477008.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  186. Shulman LN, Buswell L, Riese N, Doherty N, Loeffler JS, von Roemeling RW, Coleman CN. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors. Int J Radiat Oncol Biol Phys. 1999 May 01; 44(2):349-53. PMID: 10760430.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  187. Shulman LN. . Is anaplastic large cell lymphoma (ALCL) clinically distinct from diffuse large B cell lymphoma?. Mason DY and Harris NL, eds. Human lymphoma: clniical implications of the REAL classification. 1999; 39:0-7.
  188. Shulman LN. . The acute leukemias. Irwin RS, Cerra FB, Rippe JM, eds. Irwin and Rippe's Intensive care medicine. 1999; 1391-5.
  189. Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer. 1998 Dec 15; 83(12):2502-8. PMID: 9874455.
    Citations: 8     Fields:    Translation:Humans
  190. Shulman LN, Tarbell NJ, Storen E, Marcus K, Mauch PM. Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1113-7. PMID: 9869237.
    Citations: 1     Fields: